logo
  • HOME
  • NEWS
  • TEAM
    • OMIG Members
    • Collaborators
  • INFORMATION
    • Surgery
      • Molecular Fluorescence Guided Surgery
      • Oncocrine surgery
      • Clinical Trials
    • Endoscopy
      • Background
      • Cinical Trials
    • Bacterial Imaging
    • Tracer development
    • Equipment
  • PUBLICATIONS
  • CONTACT
  • HOME
  • NEWS
  • TEAM
    • OMIG Members
    • Collaborators
  • INFORMATION
    • Surgery
      • Molecular Fluorescence Guided Surgery
      • Oncocrine surgery
      • Clinical Trials
    • Endoscopy
      • Background
      • Cinical Trials
    • Bacterial Imaging
    • Tracer development
    • Equipment
  • PUBLICATIONS
  • CONTACT

Announcement: Paper published in Nature Communications

  • Home
  •  
  • Announcement: Paper published in Nature Communications
    • 16 OCT 18
    • 0
    Announcement: Paper published in Nature Communications

    Announcement: Paper published in Nature Communications

    We are delighted to announce that the results of the clinical phase II study on image-guided surgery using bevacizumab-IRDye800CW in patients with primary breast cancer is published in the journal Nature Communications (2017 impact factor: 12.353)

    We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes.

    The full citation is: Koller M, Qiu SQ, Linssen MD, Jansen L, Kelder W, de Vries J, Kruithof I, Zhang GJ, Robinson DJ, Nagengast WB, Jorritsma-Smit A, van der Vegt B, van Dam GM. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nat Commun. 2018 Sep 18;9(1):3789

    Leave a reply →
    • Posted in
    • News
    • Posted by
    • OMIG
© Copyright - Optical Molecular Imaging Groningen - website by GravyTrain
Top